Anxiolytic-like effects produced by bilateral lesion of the periaqueductal gray in mice: Influence of concurrent nociceptive stimulation

Behavioural Brain Research

Volumn 203, Issue 2, 2009, Pages 180-187

  Mendes Gomes, Joyce ^a   Nunes de Souza, Ricardo Luiz ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Antinociception; Anxiety; Different EPM; Dorsal periaqueductal gray; Fear; Formalin test; Mice; NMDA lesion

Indexed keywords

FORMALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ANXIETY; ARTICLE; BRAIN DAMAGE; CONTROLLED STUDY; MALE; MAZE TEST; MESENCEPHALON; MOUSE; NERVE POTENTIAL; NEUROMODULATION; NOCICEPTION; NONHUMAN; PAIN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; THALAMUS VENTRAL NUCLEUS;

ANIMALS; ANXIETY; EXPLORATORY BEHAVIOR; MALE; MICE; N-METHYLASPARTATE; PAIN; PAIN MEASUREMENT; PERIAQUEDUCTAL GRAY;

EID: 67649668917     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.04.032     Document Type: Article

References (73)

1. Abbott F.V., Franklin K.B.J., and Westbrook R.F. The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain 60 (1995) 91-102
2. Albe-Fessard D., Giamberardino M.A., and Rampim O. Comparison of different animal models of chronic pain. Adv Pain Res Ther 13 (1990) 11-25
3. Bandler R., and Shipley M.T. Columnar organization in midbrain periaqueductal gray: modules for emotional expression?. Trends Neurosci 17 (1994) 379-389
4. Basbaum A.I., and Fields H.L. Endogenous pain control system: brainstem spinal pathways and endorphin circuitry. Annu Ver Neurosci 7 (1984) 309-338
5. Behbehani M.M. Functional characteristics of the midbrain periaqueductal gray. Prog Neurobiol 46 (1995) 575-605
6. Bellgowan P.S., and Helmstetter F.J. Neural systems for the expression of hypoalgesia during nonassociative fear. Behav Neurosci 110 (1996) 727-736
7. Blanchard D.C., Williams G., Lee M.C., and Blanchard R.J. Taming of wild Rattus novergicus by lesions of the mesencephalic central gray. Physiolog Psychol 9 (1981) 157-163
8. Bolles R.C., and Fanselow M.S. A perceptual-defensive-recuperative model of fear and pain. Behav Brain Sci 3 (1980) 291-322
9. Bon K., Wilson S.G., Mogil J.S., and Roberts W.J. Genetic evidence for the correlation of deep dorsal horn Fos protein immunoreactivity with tonic formalin pain behavior. J Pain 3 (2002) 181-189
10. Brandão M.L., Troncoso A.C., De Souza Silva M.A., and Huston J.P. The relevance of neuronal substrates of defense in the midbrain tectum to anxiety and stress: empirical and conceptual considerations. Eur J Pharmacol 463 (2003) 225-233
11. Brooks J., and Tracey I. From nociception to pain perception: imaging the spinal and supraspinal pathways. J Anat 207 (2005) 19-33
12. Carrasquillo Y., and Gereau R.W. Activation of the extracellular signal-regulated kinase in the amygdala modulates pain perception. J Neurosci 27 (2007) 1543-1551
13. Carrive P. The periaqueductal gray and defensive behaviour: functional representation and neuronal organization. Behav Brain Res 58 (1993) 27-47
14. Casseday J.H., and Covey E. A neuroethological theory of the operation of the inferior colliculus. Brain Behav Evol 47 (1996) 311-336
15. Coderre T.J., Fundytus M.E., Mckenna J.E., Dalal S., and Melzack R. The formalin test: a validation of the weighted scores method of behavioural pain rating. Pain 54 (1993) 43-50
16. Conceição I.M., Maiolini Jr. M., Mattia N., Vital M.A., Santos B.R., Smaili S., et al. Anxiety-induced antinociception in the mouse. Braz J Med Biol Res 25 (1992) 831-834
17. Cornélio A.M., and Nunes-de-Souza R.L. Open elevated plus maze-induced antinociception in rats: a non-opioid type of pain inhibition?. Physiol Behav 96 (2009) 440-447
18. Deacon R.M.J., Croucher A., and Rawlins J.N.P. Hippocampal cytotoxic lesion effects on species-typical behaviours in mice. Behav Brain Res 132 (2002) 203-213
19. Dean P., Redgrave P., and Westby M. Event or emergency? Two response systems in the mammalian superior colliculus. Trends Neurosci 12 (1989) 137-147
20. De Luca-Vinhas M.C.Z., Macedo C.E., and Brandão M.L. Pharmacological assessment of the freezing, antinociception, and exploratory behaviour organized in the ventrolateral periaqueductal gray. Pain 121 (2006) 94-104
21. Dennis S.G., and Melzack R. Comparison of phasic and tonic pain in animals. In: Bonica J.J. (Ed). Advances in pain research and therapy vol. 3 (1979), Raven Press, New York 747-760
22. Depaulis A., Keay K.A., and Bandler R. Longitudinal neuronal organization of defensive reactions in the midbrain periaqueductal gray region of the rat. Exp Brain Res 90 (1992) 307-318
23. Depaulis A., Keay K.A., and Bandler R. Quiescence and hyporeactivity evoked by activation of cell bodies in the ventrolateral midbrain periaqueductal gray of the rat. Exp Brain Res 99 (1994) 75-83
24. Dielenberg R.A., Leman S., and Carrive P. Effect of dorsal periaqueductal gray lesions on cardiovascular and behavioural responses to cat odor exposure in rats. Behav Brain Res 153 (2004) 487-496
25. Dubuisson D., and Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brainstem stimulation in rats and cats. Pain 4 (1977) 161-174
26. Fanselow M.S. The midbrain periaqueductal gray as a coordinator of action in response to fear and anxiety. In: Depaulis A., and Bandler R. (Eds). The midbrain periaqueductal gray matter (1991), Plenum Press, New York 1-8
27. Fernández-Guasti A., Reyes R., Martínez-Mota L., and López-Muñoz F.J. Influence of inflammatory nociception on the anxiolytic-like effect of diazepam and buspirone in rats. Psychopharmacology 180 (2005) 399-407
28. Fields H.L., Basbaum A.I., and Heinricher M.M. Central nervous system mechanisms of pain modulation. In: McMahom S.B., and Koltzenburg M. (Eds). Wall and Melzack's textbook of pain. 5th ed. (2006), Elsevier, Churchill Livingstone 125-142
29. File S.E. Behavioural detection of anxiolytic action. In: Elliott J.M., Heal D.J., and Marsden C.A. (Eds). Experimental approaches to anxiety and depression (1992), Wiley, Chichester 25-44
30. Graeff F.G. Brain defense systems and anxiety. In: Roth M., Burrow G.D., and Noyes R. (Eds). Handbook of anxiety vol. 3 (1990), Elsevier, New York 307-354
31. Graeff F.G. Serotonin, the periaqueductal gray and panic. Neurosci Biobehav Rev 28 (2004) 239-259
32. Haghparast A., and Ahmad-Molaei L. Effects of electrolytic lesion of dorsolateral periaqueductal gray on analgesic response of morphine microinjected into the nucleus cuneiformis in rat. Neurosci Lett 451 (2009) 165-169
33. Handley S.L., and Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of fear-motivated behaviour. Naunyn Schmiedebergs Arch Pharmacol 327 (1984) 1-5
34. Harris J.A. Descending antinociceptive mechanisms in the brainstem: their role in the animal's defensive system. J Physiol Paris 90 (1996) 15-25
35. Heeb M.M., and Yahr P. Cell-body lesions of the posteriodorsal preoptic nucleus or posteriodorsal medial amygdala, but not the parvicellular subparafascicular thalamus, disrupt mating in male gerbils. Physiol Behav 68 (2000) 317-331
36. Helmstetter F.J., and Tershner S.A. Lesions of the periaqueductal gray and rostral ventromedial medulla disrupt antinociceptive but not cardiovascular aversive conditional responses. J Neurosci 14 (1994) 7099-7108
37. Hilton S.M., and Redfern W.S. A search for brainstem cell groups integrating the defence reaction in the rat. J Physiol 378 (1986) 213-228
38. Ji G., Fu Y., Ruppert K.A., and Neugebauer V. Pain-related anxiety like behaviour require CRF I receptors in the amygdala. Mol Pain 3 (2007) 1-5
39. Keay K.A., and Bandler R. Parallel circuits mediating distinct emotional coping reactions to different types of stress. Neurosci Biobehav Rev 25 (2001) 669-678
40. Keay K.A., and Bandler R. Distinct central representations of inescapable and escapable pain: observations and speculation. Exp Physiol 87 (2002) 275-279
41. Kelly D.D. Stress induced analgesia vol. 467 (1986), NY Academy of Sciences, New York
42. Le Bars D., Gozariu M., and Cadden S.W. Animal models of nociception. Pharmacol Rev 53 (2001) 597-652
43. Lee C., and Rodgers R.J. Antinociceptive effects of plus-maze exposure: influence of opiate receptor manipulations. Psychopharmacology (Berlin) 102 (1990) 507-513
44. Lee C., and Rodgers R.J. Effects of buspirone on antinociceptive and behavioural responses to the elevated plus-maze in mice. Behav Pharmacol 2 (1991) 491-496
45. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berlin) 92 (1987) 180-185
46. Lovick T.A. Interactions between descending pathways from the dorsal and ventrolateral periaqueductal gray matter in the rat. In: Depaulis A., and Bandler R. (Eds). The midbrain periaqueductal gray: functional, anatomical and neurochemical organization (1991), Plenum Press, New York 101-120
47. Lovick T.A. Integrated activity of cardiovascular and pain regulatory systems: role in adaptative behavioural responses. Prog Neurobiol 40 (1993) 631-644
48. Lumb B.M. Hypothalamic and midbrain circuitry that distinguishes between escapable and inescapable pain. News Physiol Sci 19 (2004) 22-26
49. Lumb B.M., Parry D.M., Semenenko F.M., McMullan S., and Simpson D.A. C-nociceptor activation of hypothalamic neurones and the columnar organisation of their projections to the periaqueductal grey in the rat. Exp Physiol 87 (2002) 123-128
50. Maione S., Oliva P., Marabese I., Palazzo E., Rossi F., Berrino L., et al. Periaqueductal gray matter metabotropic glutamate receptors modulate formalin-induced nociception. Pain 85 (2000) 183-189
51. McCall W.D., Tanner K.D., and Levine J.D. Formalin induces biphasic activity in C-fibers in the rat. Neurosci Lett 208 (1996) 45-48
52. Mendes-Gomes J., and Nunes-De-Souza R.L. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice. Brain Res 1047 (2005) 97-104
53. Morgan M.M. Differences in antinociception evoked from dorsal and ventral regions of the caudal and periaqueductal gray matter. In: Depaulis A., and Bandler R. (Eds). The midbrain periaqueductal gray: functional, anatomical and neurochemical organization (1991), Plenum Press, New York 139-150
54. Neugebauer V., Li W., Bird G.C., and Han J.S. The amygdala and persistent pain. Neuroscientist 10 (2004) 221-234
55. Nunes-De-Souza R.L., Canto-De-Souza A., Da-Costa M., Fornari R.V., Graeff F.G., and Pela I.R. Anxiety-induced antinociception in mice: effects of systemic and intra-amygdala administration of 8-OH-DPAT and midazolam. Psychopharmacology (Berlin) 150 (2000) 300-310
56. Parry D.M., Semenenko F.M., Conley R.K., and Lumb B.M. Noxious somatic inputs to hypothalamic-midbrain projection neurones: a comparison of the columnar organisation of somatic and visceral inputs to the periaqueductal grey in the rat. Exp Physiol 87 (2002) 117-122
57. Paxinos G., and Franklin K.B.J. The mouse brain in stereotaxic coordinates. 2nd ed. (2001), Academic Press, California
58. Pellow S., Chopin P., File S.E., and Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
59. Redgrave P., Dean P., Souki W., and Lewis G. Gnawing and changes in reactivity produced by microinjections of picrotoxin into the superior colliculus of rats. Psychopharmacology 75 (1981) 198-203
60. Rodella L., Rezzani R., Gioia M., Tredici G., and Bianchi R. Expression of Fos immunoreactivity in the rat supraspinal regions following noxious visceral stimulation. Brain Res 47 (1998) 357-366
61. Rodgers R.J. Neuropharmacological aspects of adaptative pain inhibition in murine "Victims" of aggression. Aggress Behav 21 (1995) 29-39
62. Rodgers R.J., and Johnson N.J.T. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 52 (1995) 297-303
63. Rodgers R.J., Lee C., and Shepherd J.K. Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology (Berlin) 106 (1992) 102-110
64. Siegfried B., Frischknecht H.R., and Nunes-De-Souza R.L. An ethological model for the study of activation and interaction of pain, memory and defensive systems in the attacked mouse. Role of endogenous opioids. Neurosci Biobehav Rev 14 (1990) 481-490
65. Song C., Li X., Leonard B.E., and Horrobin D.F. Effects of dietary n-3 or n-6 fatty acids on interleukin-1beta-induced anxiety, stress, and inflammatory responses in rats. J Lipid Res 44 (2003) 1984-1991
66. Steimer T., and Driscoll P. Divergent stress responses and coping styles in psychogenetically selected Roman high-(RHA) and low-(RLA) avoidance rats: behavioural, neuroendocrine and developmental aspects. Stress 6 (2003) 87-100
67. Stephens D.N., Meldrum B.S., Weidmann R., Schneider C., and Grutzner M. Does the excitatory amino acid receptor antagonist 2-APH exhibit anxiolytic activity?. Psychopharmacology (Berlin) 90 (1986) 166-169
68. Sukikara M.H., Mota-Ortiz S.R., Baldo M.V., Felicio L.F., and Canteras N.S. A role for the periaqueductal gray in switching adaptive behavioural responses. J Neurosci 26 (2006) 2583-2589
69. Tanimoto S., Nakagawa T., Yamauchi Y., Minami M., and Satoh M. Differential contributions of the basolateral and central nuclei of the amygdala in the negative affective component of chemical somatic and visceral pains in rats. Eur J Neurosci 18 (2003) 2343-2350
70. Taukulis H.K., and Goggin C.E. Diazepam-stress interactions in the rat: effects on autoanalgesia and a plus-maze model of anxiety. Behav Neural Biol 53 (1990) 205-216
71. Taylor B.K., Akana S.F., Peterson M.A., Dallman M.F., and Basbaum A.I. Pituitary-adrenocortical responses to persistent noxious stimuli in the awake rat: endogenous corticosterone does not reduce nociception in the formalin test. Endocrinology 139 (1998) 2407-2413
72. Tjolsen A., Berge O.G., Hunskaar S., Rosland J.H., and Hole K. The formalin test: an evaluation of the method. Pain 51 (1992) 5-17
73. Vanegas H., and Schaible H.G. Descending control of persistent pain: inhibitory or facilitatory?. Brain Res Rev 46 (2004) 295-309